88
Views
14
CrossRef citations to date
0
Altmetric
Review

Clinical use of crizotinib for the treatment of non-small cell lung cancer

Pages 91-101 | Published online: 26 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Seyoung Park, Eun Ryung Lee & Hongyu Zhao. (2022) Low-Rank Regression Models for Multiple Binary Responses and their Applications to Cancer Cell-Line Encyclopedia Data. Journal of the American Statistical Association 0:0, pages 1-15.
Read now
Hans Lehrach. (2016) Omics approaches to individual variation: modeling networks and the virtual patient. Dialogues in Clinical Neuroscience 18:3, pages 253-265.
Read now
Tania Losanno & Cesare Gridelli. (2016) Safety profiles of first-line therapies for metastatic non-squamous non-small-cell lung cancer. Expert Opinion on Drug Safety 15:6, pages 837-851.
Read now
Siddhartha Devarakonda, Bharath Ganesh, Janelle Mann & Ramaswamy Govindan. (2015) Crizotinib: an orphan drug for treating non-small-cell lung cancer. Expert Opinion on Orphan Drugs 3:10, pages 1209-1218.
Read now

Articles from other publishers (10)

Hyun Jung Kim. (2022) Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting. Medicina 58:5, pages 649.
Crossref
Ali Irfan, Sadia Faiz, Azhar Rasul, Rehman Zafar, Ameer Fawad Zahoor, Katarzyna Kotwica-Mojzych & Mariusz Mojzych. (2022) Exploring the Synergistic Anticancer Potential of Benzofuran–Oxadiazoles and Triazoles: Improved Ultrasound- and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules. Molecules 27:3, pages 1023.
Crossref
Nishant Kisan Rasal, Rahul Bhaskar Sonawane & Sangeeta Vijay Jagtap. (2021) Synthesis, Characterization, and Biological Study of 3‐Trifluoromethylpyrazole Tethered Chalcone‐Pyrrole and Pyrazoline‐Pyrrole Derivatives. Chemistry & Biodiversity 18:10.
Crossref
Montek Boparai, Christopher Oberc & Paul C H Li. (2021) Presence of an EML4-ALK gene fusion detected by microfluidic chip DNA hybridization. Bioscience, Biotechnology, and Biochemistry 85:2, pages 197-204.
Crossref
Magda M. F. Ismail, Dalia H. Soliman, Rehab Sabour & Amel M. Farrag. (2020) Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF‐7 cells. Archiv der Pharmazie 354:1, pages 2000214.
Crossref
Raghuram Gujjarappa, Nagaraju Vodnala & C. C. Malakar. (2020) Recent Advances in Pyridine‐Based Organocatalysis and its Application towards Valuable Chemical Transformations. ChemistrySelect 5:28, pages 8745-8758.
Crossref
Raghuram Gujjarappa, Nagaraju Vodnala, Mohan Kumar & Chandi C. Malakar. (2019) Pd-Catalyzed Decarboxylation and Dual C(sp 3 )–H Functionalization Protocols for the Synthesis of 2,4-Diarylpyridines . The Journal of Organic Chemistry 84:9, pages 5005-5020.
Crossref
Shadia A. Galal, Ahmed S. Abdelsamie, Samia A. Shouman, Yasmin M. Attia, Hamed I. Ali, Ashraf Tabll, Reem El-Shenawy, Yasmine S. El Abd, Mamdouh M. Ali, Abeer E. Mahmoud, Abeer H. Abdel-Halim, Amal A. Fyiad, Adel S. Girgis & Hoda I. El-Diwani. (2017) Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs. European Journal of Medicinal Chemistry 134, pages 392-405.
Crossref
Ali S. Abdelhameed, Amer M. Alanazi, Ahmed H. Bakheit, Hany W. Darwish, Hazem A. Ghabbour & Ibrahim A. Darwish. (2017) Fluorescence spectroscopic and molecular docking studies of the binding interaction between the new anaplastic lymphoma kinase inhibitor crizotinib and bovine serum albumin. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 171, pages 174-182.
Crossref
Kristen Kreamer & Debbie Riordan. (2015) Targeted Therapies for Non-Small Cell Lung Cancer: An Update on Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Inhibitors. Clinical Journal of Oncology Nursing 19:6, pages 734-742.
Crossref